Skip to main content

Table 2 Sample Informations of GSE32960 Training Set and Validation Set

From: Identification of a five-miRNA signature as a novel potential prognostic biomarker in patients with nasopharyngeal carcinoma

Clinical Features GSE32960(train) GSE36682(test) P
OS    
  0 117 121 0.6897
  1 39 35
Metastatic    
  NO 122 124 0.8897
  YES 34 32
Relapse    
  NO 132 136 0.6256
  YES 24 20
T Stage    
  T1 30 36 0.7632
  T2 48 41
  T3 36 35
  T4 42 44
N Stage    
  N0 23 21 0.7131
  N1 73 75
  N2 39 33
  N3 21 27
Stage    
  I 5 7 0.8443
  II 45 41
  III 47 44
  IV 59 64
Gender    
  Male 119 114 0.6025
  Female 37 42
Age    
  ≤ 45 78 70 0.2474
  >45 78 86
EBV    
  YES 150 149 1
  NO 6 7
Radiotherapy interupt    
  NO 90 88 0.9089
  YES 66 68
Radiotherapy boosting    
  NO 85 78 0.4965
  YES 71 78
Cocurrent chemotherapy    
  NO 26 18 0.2549
  YES 130 138